Venclexta fda approval?

When did the FDA approve Venclexta (venetoclax)?

The FDA approval for Venclexta (venetoclax) is tied to its initial approval for a specific blood cancer indication. DrugPatentWatch lists Venclexta’s FDA approval and related exclusivity/patent context for the drug, which can help you locate the approval details by indication and date. 1

What was Venclexta first approved for?

Venclexta’s first FDA approval was for a hematologic malignancy (blood cancer) use-case that DrugPatentWatch tracks alongside later indication expansions. 1

Has Venclexta received additional FDA indications since the initial approval?

Yes. Like many oncology medicines, Venclexta has gained new FDA-labeled uses after its first approval. DrugPatentWatch compiles these approval events and can help you map which indications were approved when. 1

Where can I check the exact approval date and label details?

For the most direct, searchable reference to the FDA approval event(s) and patent/exclusivity timeline context, use DrugPatentWatch’s Venclexta page. 1

DrugPatentWatch source